- Home
- PGHL vs VNDA Comparison
PGHL vs VNDA Comparison
Compare PGHL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- VNDA
- Stock Information
- Founded
- PGHL 2018
- VNDA 2002
- Country
- PGHL Hong Kong
- VNDA United States
- Employees
- PGHL N/A
- VNDA N/A
- Industry
- PGHL
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- VNDA Health Care
- Exchange
- PGHL NYSE
- VNDA Nasdaq
- Market Cap
- PGHL 294.2M
- VNDA 282.8M
- IPO Year
- PGHL 2024
- VNDA 2006
- Fundamental
- Price
- PGHL $0.62
- VNDA $4.77
- Analyst Decision
- PGHL
- VNDA Strong Buy
- Analyst Count
- PGHL 0
- VNDA 2
- Target Price
- PGHL N/A
- VNDA $16.50
- AVG Volume (30 Days)
- PGHL 172.4K
- VNDA 652.5K
- Earning Date
- PGHL 01-01-0001
- VNDA 05-07-2025
- Dividend Yield
- PGHL N/A
- VNDA N/A
- EPS Growth
- PGHL N/A
- VNDA N/A
- EPS
- PGHL N/A
- VNDA N/A
- Revenue
- PGHL $17,166,534.00
- VNDA $198,772,000.00
- Revenue This Year
- PGHL N/A
- VNDA $14.36
- Revenue Next Year
- PGHL N/A
- VNDA $44.53
- P/E Ratio
- PGHL $18.25
- VNDA N/A
- Revenue Growth
- PGHL 56.11
- VNDA 3.18
- 52 Week Low
- PGHL $0.61
- VNDA $3.71
- 52 Week High
- PGHL $107.36
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- VNDA 48.67
- Support Level
- PGHL N/A
- VNDA $4.84
- Resistance Level
- PGHL N/A
- VNDA $5.04
- Average True Range (ATR)
- PGHL 0.00
- VNDA 0.22
- MACD
- PGHL 0.00
- VNDA -0.01
- Stochastic Oscillator
- PGHL 0.00
- VNDA 26.32
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.